The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
NCT03006081
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Retinopathy
Interventions
DRUG:
Intravitreal Aflibercept injection
Sponsor
Asan Medical Center